3rd Quarter - Report — BIOCOM for BIOCOM (2013)

Firm

BIOCOM

Client

BIOCOM

Income

—

Expenses

$45,594

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Asked to oppose cuts to Medicare Part B and D

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—
JOE PANETTA	—

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Energy, Dept of; SENATE; Vice President of the U.S.

Financial Institutions/Investments/Securities FIN

Sent letter regarding new SEC rule on angel investors

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: SENATE; Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Vice President of the U.S.; Energy, Dept of; Food & Drug Administration (FDA)

Foreign Relations FOR

Sent a letter raising concerns over India's IP rights violation

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Vice President of the U.S.; Energy, Dept of

Health Issues HCR

Asked to support a national track and trace system, with strong pre-empting requirements Asked to support a repeal of the medical device excise tax Discussed FDA survey with FDA officials

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—
JOE PANETTA	—

Contacted: Energy, Dept of; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; Vice President of the U.S.

Economics/Economic Development ECN

Presented our 2014 Economic Impact Report

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—
JOE PANETTA	—

Contacted: Energy, Dept of; Food & Drug Administration (FDA); SENATE; Environmental Protection Agency (EPA); Vice President of the U.S.; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Asked to support the FDA SOS Act Asked for adequate funding of FDA and NIH in FY2014 Talked about impact of sequestration on FDA

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—
JOE PANETTA	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Energy, Dept of; Vice President of the U.S.; Environmental Protection Agency (EPA); SENATE

Energy/Nuclear ENG

Voiced support for the Energy Title of the Farm Bill Voiced support for renewable chemicals parity Discussed renewable energy policies

Lobbyist	Covered position, as disclosed
LAURE FABREGA CLARK	—
JOE PANETTA	—

Contacted: SENATE; Energy, Dept of; Food & Drug Administration (FDA); Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.